Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
Abroad (travel likely)RecruitingPHASE2
Conditions
Multiple Myeloma · Plasma Cell Neoplasm · Malignant Plasma Cell Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Penny Fang, MD)
Study leads
Penny Fang, MD
Principal Investigator
M.D. Anderson Cancer Center